Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,788,898
  • Shares Outstanding, K 50,224
  • Annual Sales, $ 1,309 M
  • Annual Income, $ 117,560 K
  • EBIT $ 207 M
  • EBITDA $ 311 M
  • 60-Month Beta 0.38
  • Price/Sales 2.95
  • Price/Cash Flow 12.71
  • Price/Book 4.48

Options Overview Details

View History
  • Implied Volatility 38.47% ( +1.40%)
  • Historical Volatility 31.15%
  • IV Percentile 65%
  • IV Rank 42.16%
  • IV High 57.61% on 11/06/24
  • IV Low 24.51% on 08/26/24
  • Put/Call Vol Ratio 108.60
  • Today's Volume 548
  • Volume Avg (30-Day) 975
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 13,606
  • Open Int (30-Day) 14,797

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.19
  • Number of Estimates 5
  • High Estimate 1.21
  • Low Estimate 1.17
  • Prior Year 1.04
  • Growth Rate Est. (year over year) +14.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.70 +0.99%
on 12/20/24
89.69 -15.89%
on 11/27/24
-9.48 (-11.16%)
since 11/20/24
3-Month
70.25 +7.39%
on 10/31/24
94.99 -20.58%
on 11/12/24
+0.61 (+0.82%)
since 09/20/24
52-Week
70.25 +7.39%
on 10/31/24
97.97 -23.00%
on 05/15/24
-10.75 (-12.47%)
since 12/20/23

Most Recent Stories

More News
MYGN Stock Might Gain From the New Recognition of RiskScore Study

Myriad Genetics, Inc.’s MYGN MyRisk Hereditary Cancer Test with RiskScore study has been named as one of its top 10 significant advances in genomic medicine by the American Journal of Human Genetics....

MYGN : 13.36 (+1.44%)
PEN : 242.54 (-0.40%)
PAHC : 21.69 (-0.55%)
HAE : 75.44 (-1.90%)
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Teleflex TFX recently launched its new Pressure Injectable Arrowg+ard Blue Plus MSB Procedure Kit in Europe, the Middle East and Africa (EMEA). This is regarded as a significant addition to the company’s...

TFX : 178.16 (+1.93%)
PEN : 242.54 (-0.40%)
PAHC : 21.69 (-0.55%)
HAE : 75.44 (-1.90%)
New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

Myriad Genetics, Inc.’s MYGN Prolaris prostate cancer prognostic test has been reinforced as an ‘Advanced Tool’ by the National Comprehensive Cancer Network (“NCCN”) in the fight against prostate...

MYGN : 13.36 (+1.44%)
PEN : 242.54 (-0.40%)
PAHC : 21.69 (-0.55%)
HAE : 75.44 (-1.90%)
CRL Stock to Gain From the Global Biotech Incubator Program Launch

Charles River Laboratories International, Inc. CRL has launched the Charles River Incubator Program (“CIP”) via its Global Innovation Center of Excellence (CoE). The initiative is designed to support...

PEN : 242.54 (-0.40%)
PAHC : 21.69 (-0.55%)
CRL : 185.77 (+1.99%)
HAE : 75.44 (-1.90%)
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 75.44 (-1.90%)
Haemonetics: Fiscal Q1 Earnings Snapshot

Haemonetics: Fiscal Q1 Earnings Snapshot

HAE : 75.44 (-1.90%)
Haemonetics: Fiscal Q4 Earnings Snapshot

Haemonetics: Fiscal Q4 Earnings Snapshot

HAE : 75.44 (-1.90%)
Haemonetics: Fiscal Q3 Earnings Snapshot

Haemonetics: Fiscal Q3 Earnings Snapshot

HAE : 75.44 (-1.90%)
HAEMONETICS COMPLETES ACQUISITION OF OPSENS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)
Stocks in play: OpSens Inc.

Announces that the Superior Court of Québec issued a final order today in connection with the previously ...

HAE : 75.44 (-1.90%)
OPS.TO : 2.90 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 80.34
2nd Resistance Point 79.07
1st Resistance Point 77.25
Last Price 75.44
1st Support Level 74.16
2nd Support Level 72.89
3rd Support Level 71.07

See More

52-Week High 97.97
Fibonacci 61.8% 87.38
Fibonacci 50% 84.11
Fibonacci 38.2% 80.84
Last Price 75.44
52-Week Low 70.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar